Integra Lifesciences Holdings (38)
Browse by Contract Category
Contracts
-
Form of Non-Deferred Contract Stock/Restricted Units Award Agreement (Executive Officers)
(Filed With SEC on October 26, 2022)
-
Separation Agreement and General Release, dated September 23, 2022, by and between Glenn Coleman, Integra LifeSciences Corporation and Integra LifeSciences Holdings Corporation
(Filed With SEC on September 23, 2022)
-
Form of Indemnification Agreement, by and between Integra LifeSciences Holdings Corporation and each of its directors and executive officers
(Filed With SEC on July 19, 2022)
-
First Supplemental Indenture, dated as of December 9, 2020, by and between Integra LifeSciences Holdings Corporation and Citibank, N.A., as trustee
(Filed With SEC on December 10, 2020)
-
Description of Securities
(Filed With SEC on February 24, 2022)
-
Change in Control Severance Program
(Filed With SEC on December 15, 2021)
-
Employment Agreement, dated October 28, 2021, by and between Integra LifeSciences Holdings Corporation, Integra LifeSciences Corporation and Jan De Witte
(Filed With SEC on October 28, 2021)
-
EX-101 INSTANCE DOCUMENT
(Filed With SEC on July 29, 2021)
-
Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan
(Filed With SEC on May 18, 2021)
-
Change in Control Severance Program
(Filed With SEC on December 10, 2020)
-
EX-101 INSTANCE DOCUMENT
(Filed With SEC on October 29, 2020)
-
EX-101 INSTANCE DOCUMENT
(Filed With SEC on August 10, 2020)
-
EX-101 INSTANCE DOCUMENT
(Filed With SEC on August 10, 2020)
-
Amendment, dated July 14, 2020, to that Sixth Amended and Restated Credit Agreement, among Integra LifeSciences Holdings Corporation, a syndicate of lending banks, Bank of...
(Filed With SEC on July 20, 2020)
-
Description of Securities
(Filed With SEC on February 21, 2020)
-
Additional Warrant Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley & Co. plc
(Filed With SEC on February 7, 2020)
-
Indenture, dated as of February 7, 2020, by and between Integra LifeSciences Holdings Corporation and Citibank, N.A., as trustee
(Filed With SEC on February 7, 2020)
-
Issuer Forward Repurchase Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and JPMorgan Chase Bank, National Association,...
(Filed With SEC on February 7, 2020)
-
Additional Warrant Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Wells Fargo, National Association
(Filed With SEC on February 7, 2020)
-
Additional Warrant Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Goldman Sachs & Co. LLC
(Filed With SEC on February 7, 2020)
-
Base Warrant Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Citibank, N.A
(Filed With SEC on February 7, 2020)
-
Additional Call Option Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Wells Fargo, National Association
(Filed With SEC on February 7, 2020)
-
Additional Call Option Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley & Co. International plc
(Filed With SEC on February 7, 2020)
-
Additional Call Option Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Goldman Sachs & Co. LLC
(Filed With SEC on February 7, 2020)
-
Additional Call Option Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Citibank, N.A
(Filed With SEC on February 7, 2020)
-
Base Warrant Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Wells Fargo, National Association
(Filed With SEC on February 7, 2020)
-
Base Warrant Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley & Co. International plc
(Filed With SEC on February 7, 2020)
-
Base Warrant Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Goldman Sachs & Co. LLC
(Filed With SEC on February 7, 2020)
-
Additional Warrant Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Citibank, N.A
(Filed With SEC on February 7, 2020)
-
Base Call Option Transaction Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Wells Fargo, National Association
(Filed With SEC on February 7, 2020)
-
Base Call Option Transaction Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley & Co. International plc
(Filed With SEC on February 7, 2020)
-
Base Call Option Transaction Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Goldman Sachs & Co. LLC
(Filed With SEC on February 7, 2020)
-
Base Call Option Transaction Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Citibank, N.A
(Filed With SEC on February 7, 2020)
-
Change in Control Severance Program
(Filed With SEC on December 13, 2019)
-
EX-101 INSTANCE DOCUMENT
(Filed With SEC on July 25, 2019)
-
EX-101 INSTANCE DOCUMENT
(Filed With SEC on July 25, 2019)
-
Agreement and General Release by and between Richard D. Gorelick and Integra LifeSciences Corporation
(Filed With SEC on February 26, 2019)
-
10.3 (c) Form of Indemnification Agreement for Non-Employee Director and Officers effective February 15, 2019
(Filed With SEC on February 26, 2019)